“…Our observation that all other biomarkers and metabolic parameters were similar between the two groups, while previous studies in high and low aerobically fit individuals found significant differences in e.g., lipid and protein metabolites [ 30 , 31 , 32 , 33 , 34 , 35 ], is likely related to our standardised experimental set-up, as compared to other studies. We studied healthy, young-adult females of similar age and BMI in a highly controlled setting, while previous studies were performed with metabolically impaired individuals [ 26 ], and individuals with substantially different BMIs [ 30 , 31 , 32 , 35 ], or wider age ranges [ 30 , 35 ] in experimental conditions that were less standardised [ 30 , 31 , 32 , 33 , 35 ], and these factors especially impact circulating metabolite levels [ 26 , 30 , 31 ]. Given that the levels of the analysed biomarkers and metabolic parameters were similar among the healthy females in our study, and multiple of these biomarkers and metabolic parameters showed dysregulation during disease, our findings imply that this biomarker and metabolic parameters set could be used to monitor progress from a healthy to an unhealthier state and may be used in health improvement interventions.…”